|
Journal of Zhejiang University SCIENCE A
ISSN 1673-565X(Print), 1862-1775(Online), Monthly
2024 Vol.25 No.3 P.183-205
Recent progress in the development of dielectric elastomer materials and their multilayer actuators
Abstract: Dielectric elastomers (DEs) have emerged as one of the most promising artificial muscle technologies, due to their exceptional properties such as large actuation strain, fast response, high energy density, and flexible processibility for various configurations. Over the past two decades, researchers have been working on developing DE materials with improved properties and exploring innovative applications of dielectric elastomer actuators (DEAs). This review article focuses on two main topics: recent material innovation of DEs and development of multilayer stacking processes for DEAs, which are important to promoting commercialization of DEs. It begins by explaining the working principle of a DEA. Then, recently developed strategies for preparing new DE materials are introduced, including reducing mechanical stiffness, increasing dielectric permittivity, suppressing viscoelasticity loss, and mitigating electromechanical instability without pre-stretching. In the next section, different multilayer stacking methods for fabricating multilayer DEAs are discussed, including conventional dry stacking, wet stacking, a novel dry stacking method, and micro-fabrication-enabled stacking techniques. This review provides a comprehensive and up-to-date overview of recent developments in high-performance DE materials and multilayer stacking methods. It highlights the progress made in the field and also discusses potential future directions for further advancements.
Key words: Dielectric elastomer actuator (DEA); Dielectric elastomer (DE); Material synthesis; Multilayer stacking method
1中南大学湘雅医院神经外科,国家卫生健康委肿瘤发生重点实验室,中国长沙市,410008
2中南大学湘雅医院国家老年疾病临床研究中心,中国长沙市,410008
3中南大学基础医学院肿瘤研究所,肿瘤发生与侵袭教育部重点实验室,中国长沙市,410078
4中国人民解放军总医院海南医院重症医学科,中国三亚市,572013
摘要:蛋白激酶B(Akt)通路可通过激活下游多个靶基因来调控肿瘤细胞和干细胞的生长、增殖和代谢等,从而影响一系列疾病的发生和治疗。硫酯酶超家族成员4(THEM4)作为硫酯酶超家族成员中的一员,也是Akt激酶的结合蛋白之一。癌症等疾病的机制研究发现THEM4可以与Akt结合从而调控Akt的磷酸化。最初,THEM4被认为是Akt的内源性抑制剂,在肺癌、胰腺癌和肝癌等疾病中抑制Akt的磷酸化。但随后的研究发现,THEM4在乳腺癌和鼻咽癌中通过正向调节Akt活性促进肿瘤细胞的增殖,这与之前的研究结果正好相反。面对这两种截然不同的观点,本文综述了THEM4在Akt通路中的重要作用,重点探讨了THEM4作为一种Akt结合蛋白,在各种疾病(尤其是癌症)中与Akt磷酸化的调控关系。这将有助于更好地了解THEM4联合Akt在疾病治疗中的作用。
关键词组:
References:
Open peer comments: Debate/Discuss/Question/Opinion
<1>
DOI:
10.1631/jzus.A2300457
CLC number:
Download Full Text:
Downloaded:
992
Download summary:
<Click Here>Downloaded:
417Clicked:
1422
Cited:
0
On-line Access:
2024-08-27
Received:
2023-10-17
Revision Accepted:
2024-05-08
Crosschecked:
2024-03-13